The accuracy of the clinical diagnosis of dementia with Lewy bodies continues to be relatively poor. Several neuroimaging techniques have been used to facilitate a more accurate diagnosis. Thus far, functional neuroimaging has provided the most help. This article concentrates on the use of single photon emission computed tomography (SPECT) and reports on the efficacy data available from studies investigating cerebral perfusion, cardiac scintigraphy and dopaminergic neurotransmission. The results from perfusion studies are inconsistent. Cardiac scintigraphy shows more promise, but it is not yet known whether co-morbid cardiac conditions, which are common in the elderly, will limit the clinical use of this method. The radioligand 123 I-FP-CIT binds to dopamine transporters in nigrostriatal nerve terminals and provides a way of assessing the neurodegeneration caused by Lewy body pathology. Abnormal 123 I-FP-CIT has been shown to have high sensitivity and specificity in an autopsy study and a large multicentre trial. This article aims to give an overview of the topic.
KeywordsDementia with Lewy bodies, single photon emission computed tomography (SPECT), functional imaging, perfusion imaging, neurotransmitter imaging, dopamine transporter Disclosure: Shirlony Morgan has received radiopharmaceuticals free of charge for a research project from GE Healthcare. Zuzana Walker has received consultancy payments from GE Healthcare and Bayer Schering Pharma AG and reimbursement for travel expenses for a conference from GE Healthcare. Table 1.
Dopamine Transporter ImagingDecreased concentrations of dopamine and dopamine transporters in DLB were first described in histopathological studies.